Sorting by

×

NJ

StartupGrind Princeton: Fireside Chat With Clark Lagemann

Earlier this evening, Startup Grind Princeton hosted an event at Princeton University NJ AI Hub which brought together innovators, founders, and community members to spotlight the impact of artificial intelligence across startups, healthcare, and investing. Liat Krawczyk the Director at NJ AI Hub welcomed the crowd and set the stage for a fireside chat with

StartupGrind Princeton: Fireside Chat With Clark Lagemann Read More »

NJBIZ 2025 People To Watch In Finance

1435 Capital Management is proud to announce that our Managing Partner Ben Jen has been recognized on NJBIZ‘s 2025 People To Watch In Finance list! This annual feature highlights exceptional professionals making a remarkable impact behind the scenes by driving innovation, supporting founders, and advancing the region’s finance ecosystem. Ben’s commitment to nurturing early-stage talent

NJBIZ 2025 People To Watch In Finance Read More »

TiE New Jersey Nuture Program Startup Pitch Demo Day

1435 Capital Management was honored to attend the TiE New Jersey Nurture Program Startup Pitch Demo Day yesterday. The event brought together a dynamic community of entrepreneurs, investors, and mentors, all dedicated to fostering innovation and supporting early-stage startups. We were inspired by the passion and creativity of the founders as they pitched their ventures—ranging

TiE New Jersey Nuture Program Startup Pitch Demo Day Read More »

NJ AI Hub Is Officially Open

The NJ AI Hub is officially open. Governor Phil Murphy in conjunction with the New Jersey Economic Development Authority (NJEDA), Microsoft, Princeton University, and Coreweave took place in the ribbon cutting for the inaugural facility located along New Jersey’s Route 1 Innovation Corridor. The new campus now open at 619 Alexander St in West Windsor

NJ AI Hub Is Officially Open Read More »

Funding the Future: Insights from NJ Bioscience Center’s Panel Discussion – October 26, 2024

ICYMI, the New Jersey Bioscience Center recently hosted a panel discussion exploring alternative funding sources for life sciences companies, and I found it incredibly insightful. The discussion focused on securing funding from non-traditional sources and addressed these key questions: * How were the next generation of drugs, diagnostics, and devices funded? * What new models

Funding the Future: Insights from NJ Bioscience Center’s Panel Discussion – October 26, 2024 Read More »